This week saw the return of the LSX World Congress in a real-life environment (London, to be precise).
Biotech, medtech and healthtech professionals and investors were clearly delighted to get back to face to face conversations and I joined them to see what the buzz was about. And, if we’re honest, to enjoy a spot of hospitality, networking and catching up with old friends. Conversations spanned the rather challenging current market landscape and whether deal making might pick up, post-Covid collaboration, machine learning and the role of China in the future of the industry.
Take a look at my thoughts in this quick video.
